Liminal BioSciences
Company Information
Liminal BioSciences is a Canadian biopharmaceutical company focused on discovering and developing small molecule therapeutics for metabolic, inflammatory, and fibrotic diseases. The company uses a data-driven drug discovery approach and has emphasized programs that modulate GPCR pathways. Its pipeline strategy is centered on developing differentiated candidates for diseases with meaningful unmet clinical need and partnership potential.
Industry Focus and Technologies
Small molecule pharmaceuticals, biopharmaceutical R&D, GPCR drug discovery, metabolic disease therapeutics, inflammatory disease therapeutics, fibrosis research.
Location
Laval, Quebec, Canada
Company Size and Stage
Products, Platforms or Focus Areas
Small molecule drug discovery platform, GPCR-modulating therapeutics, pipeline candidates for metabolic disease, inflammatory disease, and fibrotic disorders, plus development and partnering activities.